+1,115.4%
ARES vs IVZ
+30.7%
+1,084.7%
-50.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.3% | -0.6% | -2.8% | -3.1% |
| 7D | -0.3% | +5.1% | -5.5% | -2.7% |
| 30D | +15.3% | -1.6% | +16.8% | +15.8% |
| 3M | -5.4% | -9.1% | +3.8% | -1.3% |
| 6M | +10.0% | +1.8% | +8.2% | +8.7% |
| YTD | -14.7% | +10.8% | -25.5% | -18.8% |
| 1Y | -9.7% | +19.1% | -28.8% | -16.8% |
| 3Y | +35.8% | +144.4% | -108.6% | -10.7% |
| 5Y | +80.9% | +33.6% | +47.3% | +50.4% |
| 10Y | +1,089.9% | +41.7% | +1,048.2% | +724.6% |
| All | +1,115.4% | +30.7% | +1,084.7% | +774.5% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling